Cargando…

Peptide Receptor Radionuclide Therapy During the COVID-19 Pandemic: Are There Any Concerns?

Detalles Bibliográficos
Autores principales:	Bodei, Lisa, Bergsland, Emily, de Herder, Wouter W., Ferone, Diego, Hicks, Rodney J., Hope, Thomas A., Kunikowska, Jolanta, Pavel, Marianne, Reidy-Lagunes, Diane, Siveke, Jens, Strosberg, Jonathan, Dittmer, Ulf, Herrmann, Ken
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Society of Nuclear Medicine 2020
Materias:	Covid Commentaries
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7413236/ https://www.ncbi.nlm.nih.gov/pubmed/32576637 http://dx.doi.org/10.2967/jnumed.120.249136

Ejemplares similares

Peptide Receptor Radionuclide Therapy
por: Hofland, Johannes, et al.
Publicado: (2022)

EANM guidelines for radionuclide therapy of bone metastases with beta-emitting radionuclides
por: Handkiewicz-Junak, Daria, et al.
Publicado: (2018)

Expression of glutamate carboxypeptidase II in the glial tumor recurrence evaluated in vivo using radionuclide imaging
por: Kunikowska, Jolanta, et al.
Publicado: (2022)

Is hypertension without any other comorbidities an independent predictor for COVID‐19 severity and mortality?
por: Salazar, Martin R.
Publicado: (2020)

Clinical radionuclide therapy dosimetry: the quest for the “Holy Gray”
por: Brans, B., et al.
Publicado: (2007)

Targeted radionuclide therapy in endocrine-related cancers: advances in the last decade
por: Al-Toubah, Taymeyah, et al.
Publicado: (2023)

COVID-19 are dangerous to the kidneys in any situation, not only in a pandemic: LONG-COVID-19 and kidney disease
por: Evrin, Togay, et al.
Publicado: (2021)

Peptide Receptor Radionuclide Therapy With (177)Lu-DOTATATE for Symptomatic Control of Refractory Carcinoid Syndrome
por: Zandee, Wouter T, et al.
Publicado: (2021)

Clinical results of radionuclide therapy of neuroendocrine tumours with (90)Y-DOTATATE and tandem (90)Y/(177)Lu-DOTATATE: which is a better therapy option?
por: Kunikowska, Jolanta, et al.
Publicado: (2011)

Kidney Injury in COVID-19: an Emerging Concern to the Clinician
por: Ali, Nurshad, et al.
Publicado: (2020)

Junior doctors’ mental health and coronavirus disease safety concerns
por: Bartholomew, Alexandra, et al.
Publicado: (2022)

A Clinical Guide to Peptide Receptor Radionuclide Therapy with (177)Lu-DOTATATE in Neuroendocrine Tumor Patients
por: Becx, Morticia N., et al.
Publicado: (2022)

Prevention of exposure to and spread of COVID-19 using air purifiers: challenges and concerns
por: Ham, Seunghon
Publicado: (2020)

SARS-CoV-2-Related Kidney Injury: Current Concern and Challenges
por: Cheng, Yongqian, et al.
Publicado: (2020)

Successful neoadjuvant peptide receptor radionuclide therapy for an inoperable pancreatic neuroendocrine tumour
por: da Silva, Tiago Nunes, et al.
Publicado: (2018)

How are COVID‐19 knowledge and concern associated with practising preventive behaviours in Australian adults?
por: Khalesi, Saman, et al.
Publicado: (2021)

Strategies Towards Improving Clinical Outcomes of Peptide Receptor Radionuclide Therapy
por: Minczeles, N.S., et al.
Publicado: (2021)

Parental concerns about COVID-19 vaccine safety and hesitancy in Korea: implications for vaccine communication
por: Cho, Hye-Kyung, et al.
Publicado: (2022)

Synergism of Checkpoint Inhibitors and Peptide Receptor Radionuclide Therapy in the Treatment of Pituitary Carcinoma
por: Lin, Andrew L, et al.
Publicado: (2021)

Work‐based concerns of Australian frontline healthcare workers during the first wave of the COVID‐19 pandemic
por: Hill, Michella, et al.
Publicado: (2022)

Tandem peptide receptor radionuclide therapy using (90)Y/(177)Lu-DOTATATE for neuroendocrine tumors efficacy and side-effects - polish multicenter experience
por: Kunikowska, Jolanta, et al.
Publicado: (2020)

Is There Any Room for Women in Medical Research? Bioethical Concerns
por: Arda, Berna
Publicado: (2020)

Characteristics of healthcare personnel who reported concerns related to PPE use during care of COVID-19 patients
por: Chea, Nora, et al.
Publicado: (2022)

Income and Career Concerns Among Emerging Adults From Finland, Sweden, and the United Kingdom During COVID-19
por: Nuckols, Julia A., et al.
Publicado: (2023)

Comparative analyses of IgG/IgA neutralizing effects induced by three COVID-19 vaccines against variants of concern
por: Lafon, Eliott, et al.
Publicado: (2022)

Qualitative exploration of intentions, concerns and information needs of vaccine‐hesitant adults initially prioritised to receive COVID‐19 vaccines in Australia
por: Kaufman, Jessica, et al.
Publicado: (2022)

Radionuclide Imaging of Neurohormonal System of the Heart
por: Chen, Xinyu, et al.
Publicado: (2015)

Radionuclides: medicinal products or rather starting materials?
por: Neels, Oliver, et al.
Publicado: (2019)

Histopathologic Evaluation of COVID-19 Patients With Peripheral Arterial Thromboembolism: Does Clot Composition Make Any Sense?
por: Yesilkaya, Nihan, et al.
Publicado: (2021)

Is There Any Cardiovascular Concern Regarding the Use of Aromatase Inhibitors in Breast Cancer?
por: Galvão, Tatiana F. G.
Publicado: (2019)

Peptide receptor radionuclide therapy in patients with medullary thyroid carcinoma: predictors and pitfalls
por: Beukhof, Carolien M., et al.
Publicado: (2019)

The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours
por: Zaknun, John J., et al.
Publicado: (2013)

Provider Perceptions of a Humanizing Intervention for Health Care Workers—A Survey Study of PPE Portraits
por: Reidy, Jennifer, et al.
Publicado: (2020)

Knowledge, Attitude, and Practices Concerning Covid-19 Preventive Measures Among Healthcare Providers in Jordan
por: Amro, Fayez Majed, et al.
Publicado: (2022)

Teaching nuclear medicine in the pandemic—a new challenge for the faculty
por: Czepczyński, Rafał, et al.
Publicado: (2020)

Erratum to: The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours
por: Bodei, L., et al.
Publicado: (2013)

Hormonal crises following receptor radionuclide therapy with the radiolabeled somatostatin analogue [(177)Lu-DOTA(0),Tyr(3)]octreotate
por: de Keizer, Bart, et al.
Publicado: (2008)

COVID-19 and the mental well-being of Australian medical students: impact, concerns and coping strategies used
por: Lyons, Zaza, et al.
Publicado: (2020)

Food Handling Concerns and Practices Among Patients With Underlying Medical Conditions Associated With COVID-19 Severity
por: Trippel, Abbey, et al.
Publicado: (2021)

Bone marrow dosimetry in peptide receptor radionuclide therapy with [(177)Lu-DOTA(0),Tyr(3)]octreotate
por: Forrer, Flavio, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_nj1l3thigflgd0ddbh9lrps640